Autoimmune diseases arise when the immune system fails to recognize the body's tissues and cells as self and alternatively mounts an immune response against the tissues, considering them foreign bodies. Depending on the type of illness a person has, autoimmune conditions can influence different body areas and upset the average growth and development of organs. According to American Autoimmune Related Diseases Association (AARDA), there are as many as 80 autoimmune disorders. Many of them have similar symptoms, and it is also possible to have more than one simultaneously. Autoimmune diseases ordinarily fluctuate intervening periods of remission (little or no symptoms) and flare-ups (worsening symptoms). According to the publisher, Global Autoimmune Diseases Diagnostic Market will be US$ 8.02 Billion by 2027.
In autoimmune disease diagnostics, the autoantibody screening is acting as a medium to diagnose and monitor levels further to predict the progression of the disease. However, vague and slow to exhibit signs and symptoms present may mislead during analysis. Some of the more common symptoms of autoimmune disorders include fatigue, general feeling of being unwell (malaise), dizziness, joint pain, rash, and low-grade fever. Hence, laboratory tests are performed to diagnose autoimmune disorders depending on the particular condition the health practitioner suspects a person is suffering from. Besides, tests usually include blood tests for one or more auto antibodies. Tests for inflammation include such as C-reactive protein (CRP, the preferred test) and erythrocyte sedimentation rate (ESR).
By Type, Systemic Autoimmune Diseases and Localized Autoimmune Disease Diagnostics are two significant types of Autoimmune Disease Diagnostic. Wherein, systemic autoimmune diseases are a broad range of related diseases characterized by dysregulation of the immune system, which activates immune cells to attack autoantigens and results in inappropriate inflammation and multi-tissue damages. Moreover, vital organs such as lung and kidney involvement in systemic autoimmune diseases are common and always presented in a progressive pattern with limited treatment strategy, making them be one of the most common causes of death in patients. These diseases are frequently conducted by clinical immunology/allergy specialists and rheumatologists.
Whilst localized (organ-specific) autoimmune diseases mainly affect a single organ or tissue. The effects frequently extend to other body systems and organs. Moreover, these diseases are often managed by organ-specific medical specialists, such as endocrinologists, gastroenterologists, neurologists or rheumatologists. As per our analysis, the market shares of Localized Autoimmune Disease Diagnostics are expected to be dominant throughout the forecast period.
By disease, the market is segmented into Systemic Lupus Erythematosus, Thyroiditis, Rheumatoid Arthritis, Sjögren's Syndrome and Scleroderma. As per our analysis, Thyroiditis and Rheumatoid Arthritis are the top two most common autoimmune diseases. Wherein thyroiditis have the highest market share as per our estimation which deals with the inflammation of the thyroid gland. Many etiologists of thyroiditis involve silent or subclinical thyroiditis, transient hyperthyroidism, acute and subacute infectious thyroiditis, and chronic autoimmune thyroiditis. Thyroid function examinations are used to strengthen thyroid disease, depending on results, and thyroid antibody tests may be considered to ensure an autoimmune cause of thyroiditis. Antithyroid antibody tests include tests for thyroid peroxidase (TPO) autoantibodies (TPOAb), thyroid-stimulating hormone (TSH) receptor autoantibodies (TRAb), and thyroglobulin (Tg) autoantibodies (TgAb).
Similarly, Rheumatoid arthritis standing second in the market share is a chronic joint disease that weakens the body's joints. It is also a systemic disease that potentially affects the body's internal organs and leads to disability. Rheumatoid arthritis is the most prevalent form of autoimmune, inflammatory arthritis in adults. It can also affect children. Therefore, the current approach is to treat rheumatoid arthritis aggressively with DMARDs (disease-modifying antirheumatic drugs) soon after diagnosis. Treating rheumatoid arthritis begins, within three to 12 months after indications begin, is the most excellent way to stop or slow the rise of the disease and bring about remission. Also, ongoing (long-term) treatment with combinations of medications may offer most people the best control and prognosis of rheumatoid arthritis.
By End Users, the Autoimmune Disease Diagnostics Industry revolves around two main realms, namely Hospitals and Clinical Laboratories. Hospitals and Clinical Laboratories have well-established market share for evaluating a patient with suspected autoimmune disease. The results can strengthen a diagnosis, assess disease severity, aid in determining prognosis and are helpful to follow disease activity. Remarkably, the hospital and clinical laboratory examination components include complete blood count with differential, comprehensive metabolic panel, inflammatory markers, autoantibodies, and flow cytometry.
Based on Region, The Global Autoimmune Disease Diagnostics Market is classified into North America, Europe, Asia Pacific, Middle East & Africa and Latin America. As per our analysis, in Europe, the rising incidences of chronic diseases, the increasing geriatric population are the major factors spurring the autoimmune disease diagnosis industry growth, making it the most dominant in the market. Moreover, the Asia-Pacific is expected to show extensive market growth during the forecast period, owing to increasing disposable income and the growing patient pool in developing countries.
Globally, the patients suffering from autoimmune disease feared the COVID-19 had severe adverse reactions or that the autoimmune condition may worsen amidst the pandemic. Consequently, these patients could be at a higher risk of severe COVID-19. Hence, the health providers working consistently for the patients promoted regular autoimmune disease diagnosis booming the industry growth.
Global Autoimmune Disease Diagnostics Market has the presence of many regional players who have many outlooks in emerging countries operating at regional or country-level with expertise and experience comprises the number of players functioning in the segment for years. Some of the significant players performing in the Autoimmune Disease Diagnostics Market are Abbott Laboratories, Bio-Rad Laboratories, Roche Diagnostics, Siemens Healthineers and bioMerieux SA.
Further, these multi-national companies are developing products primarily for the autoimmune disease diagnosis segment to address the growing healthcare concerns regarding this disease. For instance, in March 2021, Roche launched Cobas pure integrated solutions analyzer to help simplify operations in small to medium-sized labs. Similarly, in May 2021, Siemens Healthineers also launched a new CT scanner for fast diagnosis and precise interventions in demanding clinical areas.
This report “Autoimmune Disease Diagnostic Market, Global Forecast By Type ( Systemic Autoimmune Disease Diagnostics and Localized Autoimmune Disease Diagnostics), Disease (Systemic Lupus Erythematosus, Thyroiditis, Rheumatoid Arthritis, Sjögren’s Syndrome, Scleroderma and Others), End Users (Hospitals, Clinical Laboratories and Others), Region (North America, Europe, Asia Pacific, Middle East & Africa and Latin America), Companies (Abbott Laboratories, Bio-Rad Laboratories, Roche Diagnostics, Siemens Healthineers and bioMerieux SA)” provides a detailed analysis of Autoimmune Disease Diagnostic Industry.
1. Systemic Autoimmune Disease Diagnostics
2. Localized Autoimmune Disease Diagnostics
1. Systemic Lupus Erythematosus
2. Thyroiditis
3. Rheumatoid Arthritis
4. Sjögren’s Syndrome
5. Scleroderma
6. Others
1. Hospitals
2. Clinical Laboratories
3. Others
1. North America
2. Europe
3. Asia Pacific
4. Middle East & Africa
5. Latin America
1. Abbott Laboratories
2. Bio-Rad Laboratories
3. Roche Diagnostics
4. Siemens Healthineers
5. bioMerieux SA
1. General Mills Inc.
2. Nestle S.A.
3. Unilever
4. Baskin Robbins
5. Lotus Bakeries
Autoimmune Disease Diagnosis and Treatment Drives the Market
In autoimmune disease diagnostics, the autoantibody screening is acting as a medium to diagnose and monitor levels further to predict the progression of the disease. However, vague and slow to exhibit signs and symptoms present may mislead during analysis. Some of the more common symptoms of autoimmune disorders include fatigue, general feeling of being unwell (malaise), dizziness, joint pain, rash, and low-grade fever. Hence, laboratory tests are performed to diagnose autoimmune disorders depending on the particular condition the health practitioner suspects a person is suffering from. Besides, tests usually include blood tests for one or more auto antibodies. Tests for inflammation include such as C-reactive protein (CRP, the preferred test) and erythrocyte sedimentation rate (ESR).
Worldwide Autoimmune Diseases Diagnostics Industry will grow with a CAGR of 8.41% during 2021 to 2027
By Type, Systemic Autoimmune Diseases and Localized Autoimmune Disease Diagnostics are two significant types of Autoimmune Disease Diagnostic. Wherein, systemic autoimmune diseases are a broad range of related diseases characterized by dysregulation of the immune system, which activates immune cells to attack autoantigens and results in inappropriate inflammation and multi-tissue damages. Moreover, vital organs such as lung and kidney involvement in systemic autoimmune diseases are common and always presented in a progressive pattern with limited treatment strategy, making them be one of the most common causes of death in patients. These diseases are frequently conducted by clinical immunology/allergy specialists and rheumatologists.
Whilst localized (organ-specific) autoimmune diseases mainly affect a single organ or tissue. The effects frequently extend to other body systems and organs. Moreover, these diseases are often managed by organ-specific medical specialists, such as endocrinologists, gastroenterologists, neurologists or rheumatologists. As per our analysis, the market shares of Localized Autoimmune Disease Diagnostics are expected to be dominant throughout the forecast period.
Thyroiditis and Rheumatoid Arthritis top two amongst the most Common Autoimmune Diseases
By disease, the market is segmented into Systemic Lupus Erythematosus, Thyroiditis, Rheumatoid Arthritis, Sjögren's Syndrome and Scleroderma. As per our analysis, Thyroiditis and Rheumatoid Arthritis are the top two most common autoimmune diseases. Wherein thyroiditis have the highest market share as per our estimation which deals with the inflammation of the thyroid gland. Many etiologists of thyroiditis involve silent or subclinical thyroiditis, transient hyperthyroidism, acute and subacute infectious thyroiditis, and chronic autoimmune thyroiditis. Thyroid function examinations are used to strengthen thyroid disease, depending on results, and thyroid antibody tests may be considered to ensure an autoimmune cause of thyroiditis. Antithyroid antibody tests include tests for thyroid peroxidase (TPO) autoantibodies (TPOAb), thyroid-stimulating hormone (TSH) receptor autoantibodies (TRAb), and thyroglobulin (Tg) autoantibodies (TgAb).
Similarly, Rheumatoid arthritis standing second in the market share is a chronic joint disease that weakens the body's joints. It is also a systemic disease that potentially affects the body's internal organs and leads to disability. Rheumatoid arthritis is the most prevalent form of autoimmune, inflammatory arthritis in adults. It can also affect children. Therefore, the current approach is to treat rheumatoid arthritis aggressively with DMARDs (disease-modifying antirheumatic drugs) soon after diagnosis. Treating rheumatoid arthritis begins, within three to 12 months after indications begin, is the most excellent way to stop or slow the rise of the disease and bring about remission. Also, ongoing (long-term) treatment with combinations of medications may offer most people the best control and prognosis of rheumatoid arthritis.
Hospitals and Clinical Laboratories have well-established market share for Evaluating a Patient with a Suspected Autoimmune Disease
By End Users, the Autoimmune Disease Diagnostics Industry revolves around two main realms, namely Hospitals and Clinical Laboratories. Hospitals and Clinical Laboratories have well-established market share for evaluating a patient with suspected autoimmune disease. The results can strengthen a diagnosis, assess disease severity, aid in determining prognosis and are helpful to follow disease activity. Remarkably, the hospital and clinical laboratory examination components include complete blood count with differential, comprehensive metabolic panel, inflammatory markers, autoantibodies, and flow cytometry.
Regional Analysis: Global Autoimmune Disease Diagnostics Market Size was US$ 4.94 Billion in 2021
Based on Region, The Global Autoimmune Disease Diagnostics Market is classified into North America, Europe, Asia Pacific, Middle East & Africa and Latin America. As per our analysis, in Europe, the rising incidences of chronic diseases, the increasing geriatric population are the major factors spurring the autoimmune disease diagnosis industry growth, making it the most dominant in the market. Moreover, the Asia-Pacific is expected to show extensive market growth during the forecast period, owing to increasing disposable income and the growing patient pool in developing countries.
Cumulative Impact of COVID-19 on Autoimmune Disease:
Globally, the patients suffering from autoimmune disease feared the COVID-19 had severe adverse reactions or that the autoimmune condition may worsen amidst the pandemic. Consequently, these patients could be at a higher risk of severe COVID-19. Hence, the health providers working consistently for the patients promoted regular autoimmune disease diagnosis booming the industry growth.
Competitive Landscape booming the Global Autoimmune Disease Diagnostics Market:
Global Autoimmune Disease Diagnostics Market has the presence of many regional players who have many outlooks in emerging countries operating at regional or country-level with expertise and experience comprises the number of players functioning in the segment for years. Some of the significant players performing in the Autoimmune Disease Diagnostics Market are Abbott Laboratories, Bio-Rad Laboratories, Roche Diagnostics, Siemens Healthineers and bioMerieux SA.
Further, these multi-national companies are developing products primarily for the autoimmune disease diagnosis segment to address the growing healthcare concerns regarding this disease. For instance, in March 2021, Roche launched Cobas pure integrated solutions analyzer to help simplify operations in small to medium-sized labs. Similarly, in May 2021, Siemens Healthineers also launched a new CT scanner for fast diagnosis and precise interventions in demanding clinical areas.
This report “Autoimmune Disease Diagnostic Market, Global Forecast By Type ( Systemic Autoimmune Disease Diagnostics and Localized Autoimmune Disease Diagnostics), Disease (Systemic Lupus Erythematosus, Thyroiditis, Rheumatoid Arthritis, Sjögren’s Syndrome, Scleroderma and Others), End Users (Hospitals, Clinical Laboratories and Others), Region (North America, Europe, Asia Pacific, Middle East & Africa and Latin America), Companies (Abbott Laboratories, Bio-Rad Laboratories, Roche Diagnostics, Siemens Healthineers and bioMerieux SA)” provides a detailed analysis of Autoimmune Disease Diagnostic Industry.
Type – Autoimmune Disease Diagnostic Market have been covered from 2 viewpoints:
1. Systemic Autoimmune Disease Diagnostics
2. Localized Autoimmune Disease Diagnostics
Disease – Autoimmune Disease Diagnostic Market have been covered from 6 viewpoints:
1. Systemic Lupus Erythematosus
2. Thyroiditis
3. Rheumatoid Arthritis
4. Sjögren’s Syndrome
5. Scleroderma
6. Others
End Users – Autoimmune Disease Diagnostic Market have been covered from 3 viewpoints:
1. Hospitals
2. Clinical Laboratories
3. Others
Region – Autoimmune Disease Diagnostic Market have been covered from 5 viewpoints:
1. North America
2. Europe
3. Asia Pacific
4. Middle East & Africa
5. Latin America
Company Insights:
- Overview
- Recent Development & Strategies
- Financial Insights
Company Covered:
1. Abbott Laboratories
2. Bio-Rad Laboratories
3. Roche Diagnostics
4. Siemens Healthineers
5. bioMerieux SA
1. General Mills Inc.
2. Nestle S.A.
3. Unilever
4. Baskin Robbins
5. Lotus Bakeries
Table of Contents
1. Introduction2. Research Methodology3. Executive Summary5. Global Autoimmune Disease Diagnostics Market
4. Market Dynamics
6. Market Share – Autoimmune Disease Diagnostics Market
7. Type – Autoimmune Disease Diagnostics Market
8. Disease – Autoimmune Disease Diagnostics Market
9. End Users – Autoimmune Disease Diagnostics Market
10. Region – Autoimmune Disease Diagnostics Market
11. Porters Five Forces
12. Company Analysis
List Of Figures:
List Of Figures:
Companies Mentioned
- Abbott Laboratories
- Bio-Rad Laboratories
- Roche Diagnostics
- Siemens Healthineers
- bioMerieux SA
Methodology
In this report, for analyzing the future trends for the studied market during the forecast period, the publisher has incorporated rigorous statistical and econometric methods, further scrutinized by secondary, primary sources and by in-house experts, supported through their extensive data intelligence repository. The market is studied holistically from both demand and supply-side perspectives. This is carried out to analyze both end-user and producer behavior patterns, in the review period, which affects price, demand and consumption trends. As the study demands to analyze the long-term nature of the market, the identification of factors influencing the market is based on the fundamentality of the study market.
Through secondary and primary researches, which largely include interviews with industry participants, reliable statistics, and regional intelligence, are identified and are transformed to quantitative data through data extraction, and further applied for inferential purposes. The publisher's in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of their recommendations and advice.
Primary Research
The primary purpose of this phase is to extract qualitative information regarding the market from the key industry leaders. The primary research efforts include reaching out to participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions. The publisher also established professional corporate relations with various companies that allow us greater flexibility for reaching out to industry participants and commentators for interviews and discussions, fulfilling the following functions:
- Validates and improves the data quality and strengthens research proceeds
- Further develop the analyst team’s market understanding and expertise
- Supplies authentic information about market size, share, growth, and forecast
The researcher's primary research interview and discussion panels are typically composed of the most experienced industry members. These participants include, however, are not limited to:
- Chief executives and VPs of leading corporations specific to the industry
- Product and sales managers or country heads; channel partners and top level distributors; banking, investment, and valuation experts
- Key opinion leaders (KOLs)
Secondary Research
The publisher refers to a broad array of industry sources for their secondary research, which typically includes, however, is not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Patent and regulatory databases for understanding of technical & legal developments
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic new articles, webcasts, and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecasts
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 118 |
| Published | November 2021 |
| Forecast Period | 2021 - 2027 |
| Estimated Market Value ( USD | $ 4.94 Billion |
| Forecasted Market Value ( USD | $ 8.02 Billion |
| Compound Annual Growth Rate | 8.4% |
| Regions Covered | Global |
| No. of Companies Mentioned | 5 |
